SCHEMBL12501263

SCHEMBL12501263

CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC)[C@H]1NC(=O)OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 5/20 0.64
▸ LGALS3 P17931 5/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ CA1 P00915 1/20 0.44
▸ LGALS7; LGALS7B P47929 2/20 0.43
▸ LGALS1 P09382 1/20 0.43
▸ LGALS9 O00182 1/20 0.43
▸ CPB1 P15086 1/20 0.43
▸ SLC6A2 P23975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12501267 1.00 LGALS8 (0.64) LGALS8LGALS3CA2CA9CA1
SCHEMBL28275633 0.94 LGALS8 (0.62) LGALS8LGALS3CA2CA9CA1
SCHEMBL10524069 0.94 LGALS8 (0.62) LGALS8LGALS3CA2CA9CA1
SCHEMBL8537936 0.91 LGALS8 (0.61) LGALS8LGALS3CA2CA9CA1
SCHEMBL9238485 0.91 LGALS8 (0.61) LGALS8LGALS3CA2CA9CA1
SCHEMBL8537938 0.91 LGALS8 (0.61) LGALS8LGALS3CA2CA9CA1
SCHEMBL10524869 0.86 LGALS8 (0.54) LGALS8LGALS3SLC6A2
SCHEMBL11322337 0.85 LMNA (0.54) LGALS8LGALS3LGALS7; LGALS7BLGALS9CPB1
SCHEMBL11325557 0.85 LMNA (0.54) LGALS8LGALS3LGALS7; LGALS7BLGALS9CPB1
SCHEMBL19976155 0.83 LGALS3 (0.68) LGALS8LGALS3LGALS7; LGALS7BLGALS1LGALS9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2668198-A1 FGF RECEPTOR-ACTIVATING 3-O-ALKYL OLIGOSACCHARIDES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2013-12-04 — — EP disclosed
WO-2012101605-A1 FGF RECEPTOR-ACTIVATING 3-O-ALKYL OLIGOSACCHARIDES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-08-02 — — WO disclosed
Send feedback